|
Focus on Safety:
AllowashXG® Technology Offers Sterility Without Compromise

With the introduction of Allowash® in 1995, LifeNet Health pioneered a revolution in allograft bio-implant cleaning and disinfection. Today, ALLOWASH XG® extends this technological leadership and ensures the utmost allograft bio-implant safety. With this technology, LifeNet Health has proudly delivered over 2.4 million allograft bio-implants with no incident of disease transmission to date.
Allowash XG® is a patented and proprietary sterilization process that removes greater than 99% of bone marrow and blood elements from the internal bone matrix. Allowash XG® renders allograft bio-implants sterile (free from microorganisms) without compromising their biomechanical or biochemical properties.
LifeNet Health demonstrates sterility of its allograft tissue processed with Allowash XG® to a 10-6 Sterility Assurance Level (SAL)1. That’s no more than a single viable particle in a million bio-implants. Other providers offer an SAL of just 10-3, which means there are as many as one in a thousand implants that could be infected. In contrast, a 10-6 SAL is the same sterility level of medical devices. And, it’s been shown that Allowash XG® gives you sterility without compromising the biomechanical or biochemical properties of LifeNet Health bio-implants needed for surgical applications. So you can be assured that you and your patients are receiving safe, healthy, effective allograft bio-implants.
To learn more about Allowash XG®, watch this short video on the LifeNet Health website.
Please contact your LifeNet Health Bio-Implant Specialist for more information about our comprehensive offering of allograft bio-implant products and services or call 888-847-7831.
1 Moore M, Linthurst Jones A, Gaskins B, et al. Adaptation of ANSI/AAMI/ISO 11137 method 2B sterilization validation for medical devices to tissue banking. Presented at: American Association of Tissue Banks Annual Meeting; Chicago, IL; August 2004
|